head JofIMAB
Journal of IMAB - Annual Proceeding (Scientific Papers)
Publisher: Peytchinski Publishing Ltd.
ISSN: 1312-773X (Online)
Issue: 2025, vol. 31, issue1
Subject Area: Medicine
-
DOI: 10.5272/jimab.2025311.5962
Published online: 23 January 2025

Original article
J of IMAB. 2025 Jan-Mar;31(1):5962-5966
INTENSE PULSED LIGHT (IPL) – TREATMENT STRATEGY FOR MEIBOMIAN GLAND DYSFUNCTION
Monika Dimitrova1, 2ORCID logoCorresponding Autoremail, Irina Kuneva2ORCID logo,
1) Department of Ophthalmology, Faculty of Medicine, Medical University of Sofia, Bulgaria.
2) Zora Eye Hospital, Sofia, Bulgaria.

ABSTRACT:
Meibomian gland dysfunction (MGD) is a primary cause of dry eye syndrome, as the meibomian glands produce lipids that maintain tear film integrity and reduce its evaporation. Blockage of these glands can result in symptoms associated with dry eye disease. Intense pulsed light (IPL) therapy is a novel treatment option for dry eye syndrome caused by MGD.
Purpose. The purpose of our study is to assess the safety and effectiveness of IPL for treating dry eye syndrome caused by MGD in various age groups, by analyzing the non-invasive tear breakup time (NITBUT) and Schirmer's test results both before and after two IPL treatments.
Materials and methods: A total of 120 subjects, each with varying degrees of MGD, underwent IPL treatment in both eyes. Each patient received two procedures spaced two weeks apart. Tear breakup time (TBUT) and Schirmer's test were evaluated at baseline and two weeks following the final treatment.
Results: The majority of tests demonstrated improvement in key clinical parameters, including tear breakup time, Schirmer's test, meibum quality, and the Standard Evaluation of Eye Dryness Questionnaire. IPL therapy shows therapeutic potential for treating MGD, enhancing tear film quality, and alleviating dry eye symptoms.
Conclusion: IPL presents a promising area for development, offering the potential for improved outcomes in patients with MGD, and is currently the focus of ongoing research.

Keywords: dry eye syndrome, meibomian gland dysfunction, non-invasive tear film breakup time, schirmer’s test, IPL treatment,

pdf - Download FULL TEXT /PDF 817 KB/
Please cite this article as: Dimitrova M, Kuneva I. Intense Pulsed Light (IPL) - Treatment strategy for Meibomian gland dysfunction. J of IMAB. 2025 Jan-Mar;31(1):5962-5966. [Crossref - 10.5272/jimab.2025311.5962]

Corresponding AutorCorrespondence to: Monika Dimitrova, Department of Ophthalmology, Faculty of Medicine, Medical University of Sofia, Zora Eye Hospital Sofia; 4, Petar Ptrotich Str., 1784, Sofia, Bulgaria; E-mail: monikk@gbg.bg

REFERENCES:
1. Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017 Jul;15(3):276-283. [PubMed]
2. Lemp MA, Crews LA, Bron AJ, Foulks GN, Sullivan BD. Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study. Cornea. 2012 May;31(5):472-8. [PubMed]
3. Montés-Micó R. Role of the tear film in the optical quality of the human eye. J Cataract Refract Surg. 2007 Sep;33(9):1631-5. [PubMed]
4. Nelson JD, Shimazaki J, Benitez-del-Castillo JM, Craig JP, McCulley JP, Den S, et al. The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci. 2011 Mar 30;52(4):1930-7. [PubMed]
5. Romero JM, Biser SA, Perry HD, Levinson DH, Doshi SJ, Terraciano A, et al. Conservative treatment of meibomian gland dysfunction. Eye Contact Lens. 2004 Jan;30(1):14-9. [PubMed]
6. Raulin C, Greve B, Grema H. IPL technology: a review. Lasers Surg Med. 2003;32:78-87. [PubMed]
7. Giannaccare G, Taroni L, Senni C, Scorcia V. Intense Pulsed Light Therapy In The Treatment Of Meibomian Gland Dysfunction: Current Perspectives. Clin Optom (Auckl). 2019 Oct 17;11:113-126. [PubMed]
8. Toyos R, McGill W, Briscoe D. Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; a 3-year retrospective study. Photomed Laser Surg. 2015 Jan;33(1):41-6. [PubMed]
9. Tashbayev B, Yazdani M, Arita R, Fineide F, Utheim TP. Intense pulsed light treatment in meibomian gland dysfunction: A concise review. Ocul Surf. 2020 Oct;18(4):583-594. [PubMed]
10. Yin Y, Liu N, Gong L, Song N. Changes in the Meibomian Gland After Exposure to Intense Pulsed Light in Meibomian Gland Dysfunction (MGD) Patients. Curr Eye Res. 2018 Mar;43(3):308-313. [PubMed]
11.  Maskin SL, Testa WR. Growth of meibomian gland tissue after intraductal meibomian gland probing in patients with obstructive meibomian gland dysfunction. Br J Ophthalmol. 2018 Jan;102(1):59-68. [PubMed]
12. Dietrich J, Garreis F, Paulsen F. Pathophysiology of Meibomian Glands - An Overview. Ocul Immunol Inflamm. 2021 May 19;29(4):803-810.  [PubMed]
13. Ahmed SA, Taher IME, Ghoneim DF, Safwat AEM. Effect of Intense Pulsed Light Therapy on Tear Proteins and Lipids in Meibomian Gland Dysfunction. J Ophthalmic Vis Res. 2019;14(1):3-10. [PubMed]
14. Gao YF, Liu RJ, Li YX, Huang C, Liu YY, Hu CX, Qi H. Comparison of anti-inflammatory effects of intense pulsed light with tobramycin/dexamethasone plus warm compress on dry eye associated meibomian gland dysfunction. Int J Ophthalmol. 2019;12(11):1708-13. [PubMed]
15. Godin MR, Stinnett SS, Gupta PK. Outcomes of Thermal Pulsation Treatment for Dry Eye Syndrome in Patients With Sjogren's Disease. Cornea. 2018;37(9):1155-8. [PubMed]
16. Steven P, Cursiefen C. Glaukom und trockenes Auge. Ophthalmologe. 2013; 110:1155–1159. [Crossref]
17. Chen HY, Lin CL, Tsai YY, Kao CH. Association between Glaucoma Medication Usage and Dry Eye in Taiwan. Optom Vis Sci. 2015 Sep;92(9):e227-32. [PubMed]
18.  Actis AG, Rolle T. Ocular surface alterations and topical antiglaucomatous therapy: a review. Open Ophthalmol J. 2014 Oct 3;8:67-72. [PubMed]
19. Gupta PK, Vora GK, Matossian C, Kim M, Stinnett S. Outcomes of intense pulsed light therapy for treatment of evaporative dry eye disease. Can J Ophthalmol. 2016;51(4):249-253. [PubMed]
20. Craig JP, Chen YH, Turnbull PR. Prospective trial of intense pulsed light for the treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2015;56:1965-70. [PubMed]

Received: 03 June 2024
Published online: 23 January 2025

back to Online Journal